A detailed history of Corient Capital Partners, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 2,121 shares of ALNY stock, worth $561,216. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,121
Previous 2,121 -0.0%
Holding current value
$561,216
Previous $309,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$120.42 - $169.29 $18,665 - $26,239
-155 Reduced 6.81%
2,121 $309,000
Q1 2022

May 16, 2022

SELL
$127.18 - $173.91 $4,578 - $6,260
-36 Reduced 1.56%
2,276 $372,000
Q4 2021

Feb 11, 2022

BUY
$159.56 - $209.29 $6,063 - $7,953
38 Added 1.67%
2,312 $392,000
Q3 2021

Nov 16, 2021

BUY
$169.75 - $207.73 $41,758 - $51,101
246 Added 12.13%
2,274 $429,000
Q2 2021

Aug 16, 2021

BUY
$128.63 - $176.89 $25,468 - $35,024
198 Added 10.82%
2,028 $344,000
Q1 2021

May 17, 2021

BUY
$126.83 - $175.69 $27,775 - $38,476
219 Added 13.59%
1,830 $258,000
Q4 2020

Feb 12, 2021

BUY
$122.97 - $147.0 $198,104 - $236,817
1,611 New
1,611 $209,000
Q3 2020

Nov 16, 2020

SELL
$121.19 - $165.49 $176,937 - $241,615
-1,460 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$104.21 - $156.44 $152,146 - $228,402
1,460 New
1,460 $216,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $32.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.